| Seclusion and restraint in psychiatry: patients' experiences and practical suggestions on how to improve practices and use alternatives R Kontio, G Joffe, H Putkonen, L Kuosmanen, K Hane, M Holi, M Välimäki Perspectives in psychiatric care 48 (1), 16-24, 2012 | 246 | 2012 |
| Patient restrictions: are there ethical alternatives to seclusion and restraint? R Kontio, M Välimäki, H Putkonen, L Kuosmanen, A Scott, G Joffe Nursing ethics 17 (1), 65-76, 2010 | 165 | 2010 |
| Therapeutic alliance in guided internet therapy programs for depression and anxiety disorders–a systematic review S Pihlaja, JH Stenberg, K Joutsenniemi, H Mehik, V Ritola, G Joffe Internet interventions 11, 1-10, 2018 | 136 | 2018 |
| Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial J Tiihonen, P Halonen, K Wahlbeck, E Repo-Tiihonen, S Hyvarinen, ... Journal of Clinical Psychiatry 66 (8), 1012-1015, 2005 | 132 | 2005 |
| Differences and similarities of risk factors for suicidal ideation and attempts among patients with depressive or bipolar disorders K Aaltonen, P Näätänen, M Heikkinen, M Koivisto, I Baryshnikov, ... Journal of affective disorders 193, 318-330, 2016 | 85 | 2016 |
| Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study K Wahlbeck, M Cheine, K Tuisku, A Ahokas, G Joffe, R Rimón Progress in Neuro-Psychopharmacology and Biological Psychiatry 24 (6), 911-922, 2000 | 81 | 2000 |
| Secluded and restrained patients' perceptions of their treatment P Soininen, M Välimäki, T Noda, P Puukka, J Korkeila, G Joffe, ... International Journal of Mental Health Nursing 22 (1), 47-55, 2013 | 80 | 2013 |
| Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial G Joffe, V Terevnikov, M Joffe, JH Stenberg, M Burkin, J Tiihonen Schizophrenia research 108 (1-3), 245-251, 2009 | 78 | 2009 |
| Orlistat in clozapine-or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial. G Joffe, P Takala, E Tchoukhine, H Hakko, M Raidma, H Putkonen, ... Journal of Clinical Psychiatry 69 (5), 706-711, 2008 | 78 | 2008 |
| Relationships between self-reported childhood traumatic experiences, attachment style, neuroticism and features of borderline personality disorders in patients with mood disorders I Baryshnikov, G Joffe, M Koivisto, T Melartin, K Aaltonen, K Suominen, ... Journal of affective disorders 210, 82-89, 2017 | 67 | 2017 |
| Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: a nationwide registry-based prospective cohort study E Toffol, T Hätönen, A Tanskanen, J Lönnqvist, K Wahlbeck, G Joffe, ... Journal of Affective Disorders 183, 159-165, 2015 | 64 | 2015 |
| A comparison of mental health care systems in Northern and Southern Europe: a service mapping study M Sadeniemi, N Almeda, JA Salinas-Pérez, MR Gutiérrez-Colosía, ... International journal of environmental research and public health 15 (6), 1133, 2018 | 46 | 2018 |
| Anxiety symptoms in a major mood and schizophrenia spectrum disorders B Karpov, G Joffe, K Aaltonen, J Suvisaari, I Baryshnikov, P Näätänen, ... European Psychiatry 37, 1-7, 2016 | 46 | 2016 |
| Addon mirtazapine improves depressive symptoms in schizophrenia: a doubleblind randomized placebocontrolled study with an openlabel extension phase V Terevnikov, JH Stenberg, J Tiihonen, M Joffe, M Burkin, E Tchoukhine, ... Human Psychopharmacology: Clinical and Experimental 26 (3), 188-193, 2011 | 46 | 2011 |
| Influence of patient characteristics on duration of seclusion/restrain in acute psychiatric settings in J apan T Noda, N Sugiyama, M Sato, H Ito, E Sailas, H Putkonen, R Kontio, ... Psychiatry and Clinical Neurosciences 67 (6), 405-411, 2013 | 45 | 2013 |
| Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study JH Stenberg, V Terevnikov, M Joffe, J Tiihonen, E Tchoukhine, M Burkin, ... International Journal of Neuropsychopharmacology 13 (4), 433-441, 2010 | 43 | 2010 |
| Randomized controlled trials of add-on antidepressants in schizophrenia V Terevnikov, G Joffe, JH Stenberg International Journal of Neuropsychopharmacology 18 (9), pyv049, 2015 | 40 | 2015 |
| Nurses' and physicians' educational needs in seclusion and restraint practices R Kontio, M Välimäki, H Putkonen, A Cocoman, S Turpeinen, ... Perspectives in psychiatric care 45 (3), 198-207, 2009 | 40 | 2009 |
| Toward a safer working environment on psychiatric wards: service users' delayed perspectives of aggression and violence-related situations and development ideas. R Kontio, M Anttila, T Lantta, K Kauppi, G Joffe, M Välimäki Perspectives in Psychiatric Care 50 (4), 2014 | 39 | 2014 |
| Orlistat in clozapine-or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial E Tchoukhine, P Takala, H Hakko, M Raidma, H Putkonen, P Räsänen, ... The Journal of clinical psychiatry 71 (3), 13548, 2010 | 39 | 2010 |
